Akar F, Skinner E, Klein J D, Jena M, Paul R J, O'Neill W C
Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Am J Physiol. 1999 Jun;276(6):C1383-90. doi: 10.1152/ajpcell.1999.276.6.C1383.
Little is known about the function and regulation of the Na+-K+-2Cl- cotransporter NKCC1 in vascular smooth muscle. The activity of NKCC1 was measured as the bumetanide-sensitive efflux of 86Rb+ from intact smooth muscle of the rat aorta. Hypertonic shrinkage (440 mosmol/kgH2O) rapidly doubled cotransporter activity, consistent with its volume-regulatory function. NKCC1 was also acutely activated by the vasoconstrictors ANG II (52%), phenylephrine (50%), endothelin (53%), and 30 mM KCl (54%). Both nitric oxide and nitroprusside inhibited basal NKCC1 activity (39 and 34%, respectively), and nitroprusside completely reversed the stimulation by phenylephrine. The phosphorylation of NKCC1 was increased by hypertonic shrinkage, phenylephrine, and KCl and was reduced by nitroprusside. The inhibition of NKCC1 significantly reduced the contraction of rat aorta induced by phenylephrine (63% at 10 nM, 26% at 30 nM) but not by KCl. We conclude that the Na+-K+-2Cl- cotransporter in vascular smooth muscle is reciprocally regulated by vasoconstrictors and nitrovasodilators and contributes to smooth muscle contraction, indicating that alterations in NKCC1 could influence vascular smooth muscle tone in vivo.
关于血管平滑肌中钠-钾-2氯协同转运蛋白NKCC1的功能和调节知之甚少。NKCC1的活性通过从大鼠主动脉完整平滑肌中布美他尼敏感的86Rb+外流来测量。高渗收缩(440 mosmol/kgH2O)使协同转运蛋白活性迅速加倍,与其容积调节功能一致。NKCC1也被血管收缩剂血管紧张素II(52%)、去氧肾上腺素(50%)、内皮素(53%)和30 mM氯化钾(54%)急性激活。一氧化氮和硝普钠均抑制基础NKCC1活性(分别为39%和34%),且硝普钠完全逆转了去氧肾上腺素的刺激作用。高渗收缩、去氧肾上腺素和氯化钾可增加NKCC1的磷酸化,而硝普钠可使其降低。抑制NKCC1可显著降低去氧肾上腺素诱导的大鼠主动脉收缩(10 nM时为63%,30 nM时为26%),但对氯化钾诱导的收缩无影响。我们得出结论,血管平滑肌中的钠-钾-2氯协同转运蛋白受血管收缩剂和硝基血管扩张剂的相互调节,并有助于平滑肌收缩,这表明NKCC1的改变可能会影响体内血管平滑肌张力。